These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36066506)

  • 1. Emerging therapies for juvenile arthritis: agents in early clinical trials.
    Rosina S; Giancane G; Ruperto N
    Expert Opin Investig Drugs; 2022 Oct; 31(10):1109-1124. PubMed ID: 36066506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigational drugs for treatment of juvenile idiopathic arthritis.
    Mauro A; Rigante D; Cimaz R
    Expert Opin Investig Drugs; 2017 Apr; 26(4):381-387. PubMed ID: 28277884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis.
    McMahan R; Balfe LM; Greene L
    J Manag Care Pharm; 2012; 18(1 Suppl B):1-16. PubMed ID: 22376227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis.
    Hayward K; Wallace CA
    Arthritis Res Ther; 2009; 11(1):216. PubMed ID: 19291269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines on biologic drugs for the treatment of children with juvenile idiopathic arthritis (JIA)].
    Bukovac LT; Vidović M; Lamot L; Perica M; Harjacek M;
    Reumatizam; 2013; 60(1):57-66. PubMed ID: 24003687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT).
    Ramanan AV; Guly CM; Keller SY; Schlichting DE; de Bono S; Liao R; Quartier P
    Trials; 2021 Oct; 22(1):689. PubMed ID: 34627340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab for treating juvenile idiopathic arthritis.
    Turnier JL; Brunner HI
    Expert Opin Biol Ther; 2016; 16(4):559-66. PubMed ID: 26848760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile idiopathic arthritis.
    Martini A; Lovell DJ; Albani S; Brunner HI; Hyrich KL; Thompson SD; Ruperto N
    Nat Rev Dis Primers; 2022 Jan; 8(1):5. PubMed ID: 35087087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries.
    Swart J; Giancane G; Horneff G; Magnusson B; Hofer M; Alexeeva Е; Panaviene V; Bader-Meunier B; Anton J; Nielsen S; De Benedetti F; Kamphuis S; Staņēviča V; Tracahana M; Ailioaie LM; Tsitsami E; Klein A; Minden K; Foeldvari I; Haas JP; Klotsche J; Horne AC; Consolaro A; Bovis F; Bagnasco F; Pistorio A; Martini A; Wulffraat N; Ruperto N;
    Arthritis Res Ther; 2018 Dec; 20(1):285. PubMed ID: 30587248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
    Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
    Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research progress in drug therapy of juvenile idiopathic arthritis.
    Zhao WJ; Deng JH; Li CF
    World J Pediatr; 2022 Jun; 18(6):383-397. PubMed ID: 35364799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological disease-modifying antirheumatic drugs in juvenile idiopathic arthritis of polyarticular course, enthesitis-related arthritis, and psoriatic arthritis: a consensus statement.
    Ho ACH; Wong SN; Leung LCK; Chan WKY; Chong PCY; Tse NKC; Yeung RHM; Kong SY; Lee KP
    Hong Kong Med J; 2020 Feb; 26(1):56-65. PubMed ID: 32077861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile idiopathic arthritis - what the clinician needs to know.
    Kahn PJ
    Bull Hosp Jt Dis (2013); 2013; 71(3):194-9. PubMed ID: 24151944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of juvenile idiopathic arthritis: what's new?
    Giancane G; Ruperto N;
    Curr Opin Rheumatol; 2019 Sep; 31(5):428-435. PubMed ID: 31169547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of juvenile idiopathic arthritis: a revolution in care.
    Stoll ML; Cron RQ
    Pediatr Rheumatol Online J; 2014; 12():13. PubMed ID: 24782683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: A systematic review.
    Davies R; Gaynor D; Hyrich KL; Pain CE
    Semin Arthritis Rheum; 2017 Apr; 46(5):584-593. PubMed ID: 27914689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologics in juvenile idiopathic arthritis: a narrative review.
    Vanoni F; Minoia F; Malattia C
    Eur J Pediatr; 2017 Sep; 176(9):1147-1153. PubMed ID: 28725955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering the hidden socioeconomic impact of juvenile idiopathic arthritis and paving the way for other rare childhood diseases: an international, cross-disciplinary, patient-centered approach (PAVE Consortium).
    Marshall DA; Gerber B; Currie GR; Antón J; De Somer L; Dey M; Egert T; Egert Y; Henan L; Klotsche J; Mifsut LM; Minden K; Normand C; Porte D; Saurenmann RK; Swart JF; Uziel Y; Wilson J; Wouters C; Ziv A; Benseler SM;
    Pediatr Rheumatol Online J; 2024 Aug; 22(1):74. PubMed ID: 39118107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook.
    Selvestrel D; Lucafò M; Pugnetti L; Pagarin S; Moressa V; Pastore S; Taddio A; Stocco G; Decorti G
    Expert Rev Clin Immunol; 2021 Oct; 17(10):1131-1142. PubMed ID: 34392756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
    Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.